Apolipoprotein A-V (APOA5) antibody

Details for Product No. ABIN268873
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms RAP3, Apoav, 1300007O05Rik, APOAV, apo-AV, apoA-V, APOA5, MGC140487, rap3, apoav, apoa-v
Reactivity
Human
(97), (17), (15), (12), (8), (1)
Host
Mouse
(61), (42), (4)
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
(4), (3), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1)
Application
Western Blotting (WB), ELISA
(84), (80), (14), (13), (10), (7), (4), (3), (2), (1)
Pubmed 2 references available
Catalog no. ABIN268873
Quantity 25 µL
Price
Contact our Customer Service for availability and price in your country.
Shipping to United States (Change)
Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Ni-NTA purified full-length recombinant human APOA5 expressed in E. Coli strain BL21(DE3).
Clone 1G5G9
Isotype IgG1
Specificity Species Reactivity: Reacts with human. 83% sequence identity with Bovine, 79% sequence identity withRat, 78% sequence identity with Mouse proteins.
Cross-Reactivity Human
Alternative Name Apolipoprotein A V (ApoA V)
Background Apolipoprotein A5 (ApoA5) is fast gaining attention as a key regulator of serumtriglyceride concentrations. An ApoA5 mouse knock-out model produced anapproximately four-fold increase in serum triglycerides, whereas a knock-in model withhuman ApoA5 produced 50-70% lower concentrations of mouse serum triglycerides. Inaddition, peroxisome proliferator-activated receptor-4 (PPAR-alpha) agonists, which areused clinically to lower serum triglyceride concentrations, cause increased ApoA5mRNA expression. Recently, it was demonstrated that ApoA5 is present in humanserum detected by polyclonal antibodies against both the NH2 and COOH termini,although at much lower concentrations than other apolipoproteins. Alternate Names: anti-Apo-A5 antibody, anti-ApoA5 antibody, anti-Apolipoprotein A5 antibody, anti-ApoA-V antibody, anti-Apolipoprotein A-V antibody, anti-ApoA-V antibody. Related Diseases: Coronary Artery Disease, Hypertriglyceridemia
Gene ID 116519
Research Area Metabolism
Application Notes Suggested working dilutions: Western Blot 1:500-1:2,000 (ECL). Positive Controls: HEPG2 cells
Restrictions For Research Use only
Format Liquid
Concentration 3.6 mg/ml
Storage -20 °C
General Pennacchio, Olivier, Hubacek et al.: "An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing." in: Science (New York, N.Y.), Vol. 294, Issue 5540, pp. 169-73, 2001 (PubMed).

Prieur, Coste, Rodriguez: "The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element." in: The Journal of biological chemistry, Vol. 278, Issue 28, pp. 25468-80, 2003 (PubMed).

Hosts (61), (42), (4)
Reactivities (97), (17), (15), (12), (8), (1)
Applications (84), (80), (14), (13), (10), (7), (4), (3), (2), (1)
Conjugates (4), (3), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1)
Epitopes (11), (11), (3), (1), (1), (1), (1), (1), (1)
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Validation Images
back to top